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Education and debate
Evaluating complementary medicine: methodological
challenges of randomised controlled trials
Su Mason, Philip Tovey, Andrew F Long
Complementary medicine is increasingly popular for treating many different problems. Doctors and
patients need evidence about complementary treatments, but randomised controlled trials need to
be carefully designed to take holism into account and avoid invalid results Topic: 20;149;171
You think that by understanding one, you can
understand two, for one and one is two. But to under›
stand two, you must first understand “and.”
Sufi saying1
Complementary medicine should be evaluated as
rigorously as conventional medicine to protect the
public from charlatans and unsafe practices,2–5 but
many practitioners of complementary medicine are
reticent about evaluation of their practice. Sceptics
maintain that this is because of fear that investigations
will find treatments ineffective and threaten livelihoods.
In defence, many practitioners argue that research
methods dissect their practice in a reductionist manner
and fail to take into account complementary
medicine’s holistic nature leading to invalid evaluation.
Nature of complementary medicine
Complementary medicine comprises many different
disciplines, a wide spectrum of practices and philoso›
phies which differ from conventional medicine.
Conventional medicine traditionally aims to diagnose
illness and treat, cure, or alleviate symptoms. Many
complementary disciplines aim not only to relieve
symptoms and restore wellness but also to help
individuals in a process of self healing within a holistic
view of health. In this view, individuals are more than
just mind, body, and spirit in a social—family or work—
environment: as well as promoting wellness, some
complementary medicine contains a philosophy that
everything is interconnected, and consequently intrin›
sically bound in a therapeutic relationship between the
individual and practitioner.1
Linked to the idea of self healing is a spiritual com›
ponent: some complementary practitioners believe
that illness has a corrective purpose, showing the
underlying disharmony in people’s lives and enabling
identification of areas for change.6 Illness is, in addition,
recognised as complex, embracing factors such as
genetic predisposition, environment, and diet. Conven›
tional medical relief of symptoms or even “cure” may
be considered a temporary respite if the individual
does not tackle the underlying cause—for example, by
releasing suppressed anger, forgiving, or reducing
stress by changing job or being more accepting of cir›
cumstances. Complementary treatment aims to be tai›
lored to the individual’s stage in life, exploring different
underlying causes and solutions.
The challenge for research methodology is to fuse
the philosophical concerns of stakeholders with the
highest standards of methodological rigour. Taking
complementary practitioners’ criticisms of randomised
controlled trials seriously enables methods to be modi›
fied so that the concerns of all stakeholders are taken
into account. This ensures that as far as possible what is
being assessed under experimental conditions is
consistent with everyday complementary practice. In
this paper, we consider the core methodological
difficulties in assessing complementary medicine and
offer practical solutions.7–9 Some evidence from
unmodified trials can be rejected as invalid and is
therefore ignored; anecdotes from practice are rejected
as meaningless. Unless evidence is generated in a way
that satisfies all parties, it is unlikely to have an impact
Summary points
Complementary medicine has a different
philosophy from conventional medicine,
presenting challenges to research methodology
Rigorous evaluation of complementary medicine
could provide much needed evidence of its
effectiveness
Good design of randomised controlled trials will
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Practitioners need to be recognised as a
component in or contributor to complementary
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Both specific and non›specific outcome measures
with long follow up are needed to adequately
encompass the essence of complementary
medicine
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on the objective of having evidence based decision
making and practice.
Challenges in research methodology
Sampling
Separation of organisations—Complementary care
within European countries is generally separate to
conventional medicine. Complementary medicine is
not usually integrated into national health systems, and
individuals pay for treatment. Funding for trials should
include the additional costs of complementary
treatment. Additional complexities require attention;
these include legal indemnity for the practitioners tak›
ing part and assurances of their professional and tech›
nical competence.
Generalisability—Because complementary and con›
ventional care are separate, patients recruited to a trial
comparing the two may differ from typical comple›
mentary patients since they themselves did not decide
which treatment they would receive. For example,
belief systems or coping mechanisms might differ,
affecting treatment outcomes. Incorporating prefer›
ence in the design of the trial might help tackle and
investigate this problem.
Therapeutic expectation—Choosing or preferring a
particular complementary discipline carries an associ›
ated implicit belief in benefit. Such credibility and
expectation of therapeutic gain can bias the results of
trials, especially if they cannot be blinded (as in a trial
of yoga practice or tai chi). Expectation and perceived
credibility should be acknowledged and assessed at
randomisation. Several controlled trials have used a
credibility scale to check the equivalence of psychologi›
cal treatments.10 11
Wide range of symptoms—Complementary medicine
and subsequent diagnosis are often not used because
of a specific disease. Instead, users may feel tired, lack
energy, or be unhappy. A trial about the effectiveness of
an intervention based on a disease may not be relevant
to complementary treatments. Trials may need to focus
on problem areas which are independent of categories
of disease. Broad and appropriate outcome measures
should capture a wide range of symptoms.
Treatment
Standardisation—Within a complementary disci›
pline, treatment is individualised and includes care
associated with an individual’s “diagnosis” and the spe›
cific practitioner (skills, competence, manner, etc). The
practitioner is explicitly recognised as a component of
or contributor to the treatment. This may conflict with
ideas of standardisation in conventional trials. Com›
plex treatment interventions can be investigated prag›
matically. Standardised treatment can be interpreted as
treating to a standard regimen, defined in a protocol,
rather than exactly the same treatment. Randomisation
should include stratification by individual practitioner.
Influence of practitioner and user—Practitioners often
claim that they do not just carry out a set of
techniques—for example, the remedy in herbalism or
the needles in acupuncture—on the user. They claim to
understand how to improve the healing process, the
user’s role in the healing process, and the therapeutic
relationship between the user and the practitioner. All
aspects of complementary care should be assessed, and
the human experience should be retained as central
(not marginalised, as often occurs in reductionist
methods).12 If a trial design includes modified therapies
so that the holistic aspect is excluded, then this must be
explicitly stated.
Controls—Choosing an appropriate comparison
group in trials of complementary medicine trials is
often problematic. Sham controls—for example,
dummy acupuncture to create a placebo controlled
comparison—should be treated with caution as they
are artificial experiences and distort practice. Any ben›
efit over standard medical treatment should be
assessed and appropriate controls adopted. For some
complementary treatments—for example, homoeopa›
thy and herbalism—the traditional blinded randomised
controlled trial is appropriate. For treatments in which
blinding is not possible—for example, meditation—
emphasis should be on pragmatic trials with conven›
tional medical practice as controls.
Understanding complementary processes—It is difficult
to define precisely which aspect of a complementary
treatment provides benefit. During spiritual healing, is
it the intent to heal, the preparation, the channelling of
“energy,” the accompanying non›judgmental listening
to the user, the relationship with the healer, the healing
environment, users’ expectations or attitudes, or all of
these which are important? Complex interventions in
conventional medicine result in similar problems.13 Too
often trials provide both limited detail on the actual
process and little insight into what component of the
intervention leads to the effect. Qualitative methods
should be used to investigate the process. The design of
the trial should address the therapeutic relationship
and non›specific effects, in addition to any specific
treatment effects.14 At the same time, from the user’s
perspective, it is the beneficial effect itself that matters,
not how it was brought about.
Outcome measures
Appropriate outcome measures—Capturing the
essence of how complementary medicine might help
people is an important challenge. Noteworthy changes
after treatment, such as spiritual change or personal
growth, might not be measurable. Choice of outcome
criteria in the evaluation of complementary therapies
“may make a substantial difference to conclusions as to
Acupuncture is a popular complementary treatment
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whether a particular intervention or therapy is effective
or not.”14 Holism, which is central to the philosophy
and practice of much complementary medicine, needs
to be better understood. Detailed qualitative studies,
accompanying a trial, could elicit these more elusive
outcomes and aim to take account of experiential out›
come criteria, such as increased self reflection.
Illness role—According to some complementary
philosophies, illness indicates an imbalance in the body
and symptoms of illness draw attention to this. For
example, individuals develop colds, backache, or
eczema when they are under stress or run down. If
complementary medicine helps people recognise
imbalance and adverse lifestyle factors that contribute
to illness and promotes change and resultant improve›
ments in health, then research needs to capture these
changes.
Chronic illness—Complementary treatment is often
sought by people with chronic illnesses who may not
have responded to conventional treatment or may
want to explore different forms of care. Any change is
likely to be gradual and subtle and to have a relapsing
and remitting pattern. As complementary interven›
tions tend to aim for long term healing, and not neces›
sarily cure, they are well suited to help people with
chronic illness. Funding bodies must understand that
long term follow up of outcomes (specific and
non›specific) is needed for results to be meaningful.
Randomised controlled trials work best for exploring
short term effects. Over time, factors other than the
trial treatments could bring about the observed effects.
Variations in experience—One person can have
different experiences of complementary medicine at
different times; different people can have widely differ›
ent experiences. Designing a trial to investigate a treat›
ment that might be effective immediately for one
person but take months to be effective for another is a
problem. A “healing moment” may occur at the time of
treatment or some time after. Appropriate experiential
outcome measures should take variations into account
along with adequately long follow up periods.
Sick role—Some users do not respond to treatment.
There are those who adapt to the sick role because they
have an investment in staying ill. Others may be
satisfied with the short fix, of feeling peaceful and
relaxed, that is offered by many complementary
treatments and may not take responsibility to make the
necessary changes to improve their health. In
principle, randomised controlled trials provide an effi›
cient way to deal with this problem. People adopting
the sick role should be distributed equally throughout
the arms of a trial through the randomisation process.
Conclusion
Researchers need to tackle the complex issues in
researching complementary medicine. Studies should
be designed to enable a valid evaluation of comple›
mentary medicine, on multiple levels, in the human
healing process.
People often turn to complementary treatments
because of frustration with conventional medicine.15
They seek that “more”—the essence of what is valued—
that complementary treatments offer. Research into
complementary medicine has a challenge not to miss
the “more” and not to design inappropriately to find it.
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